RecallRadar

FDA Drug recall D-0286-2025

Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use O…

On 2025-03-26 the FDA classified a Class II recall of Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use O… by Amgen, citing stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0286-2025
ClassificationClass II
Statusongoing
Initiated2025-02-27
Published2025-03-26
Last updated2026-09-13 11:52 UTC
CompanyAmgen
DistributionUS

Product

Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc. Thousand Oaks, CA 91320, NDC 55513-546-01 (vial), NDC 55513-546-10 (box).

Reason

Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.

Identifiers

ndc55513-530-01
ndc55513-530-10
ndc55513-530-20
ndc55513-546-01
ndc55513-546-10
ndc55513-546-20
ndc55513-924-01
ndc55513-924-10
ndc55513-924-91
ndc55513-924-20
ndc55513-209-01
ndc55513-209-10
ndc55513-209-91
ndc55513-209-20
code_info
Lot 1147308, 1154183, Exp.: 2/28/2025; 1156807, 1160222, Exp.: 6/30/2025; 1160223, 1163912, 1167352, Exp.: 2/28/2026; 1…Lot 1147308, 1154183, Exp.: 2/28/2025; 1156807, 1160222, Exp.: 6/30/2025; 1160223, 1163912, 1167352, Exp.: 2/28/2026; 1171365, 1175057, 1176250, Exp.: 11/30/2026.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0286-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.